The Patent Office in India is not a standalone act or scheme, but an institution that functions as a subordinate office under the Controller General of Patents, Designs and Trade Marks (CGPDTM), which is part of the Department for Promotion of Industry and Internal Trade (DPIIT) under the Ministry of Commerce and Industry. Its origin traces back to the first legislation for exclusive privileges for inventions, promulgated on February 28, 1856, which solved the problem of encouraging new manufactures by granting the first patent-like protection to civil engineer George Alfred DePenning. The modern framework is governed by the Patents Act, 1970, which replaced the colonial-era Patents and Designs Act, 1911, to foster domestic industrial growth and prevent foreign monopolies.
The Patent Office works by administering the Patents Act, 1970, which grants a 20-year exclusive right to an inventor for an invention that meets the criteria of novelty, inventive step, and industrial applicability, as defined in Section 2(1)(j). Key mechanisms include the examination of applications to ensure they are not excluded under Section 3 (e.g., mere discoveries or scientific theories) and the provision for opposition proceedings, which allow third parties to challenge a patent's validity before or after its grant under Section 25. A crucial provision is Section 84, which allows the Controller to issue a compulsory license to a third party without the patent owner's consent in situations of public interest, such as to ensure access to essential goods.
The Patent Office connects to the broader Intellectual Property (IP) ecosystem, as the CGPDTM also administers the laws for Designs, Trade Marks, and Geographical Indications. The Patents Act, 1970, has been amended multiple times, notably in 1999, 2002, and 2005, to align India's IP regime with the World Trade Organization's (WTO) TRIPS Agreement, which required a shift to product patents in sectors like pharmaceuticals. Recent changes include the Patents Amendment Rules, 2024, which changed the due date for filing a Request for Examination (RFE) from 48 months to 31 months from the earliest priority date for applications filed on or after March 15, 2024. Additionally, the requirement for patentees to file working statements (Form 27) was changed from annually to once every three financial years. The core rights of the patentee under Section 48 and the 20-year term of protection have stayed the same.